HOME > BUSINESS
BUSINESS
- Kissei Grants Linzagolix Rights to Searchlight in Canada
October 8, 2025
- Enhertu Combo Filed for First-Line HER2 Breast Cancer in Japan
October 8, 2025
- Leqembi Iqlik Autoinjector Now Available in US: Eisai/Biogen
October 8, 2025
- Japan Ethical Drug Sales Edge Up 0.4% in August: Crecon
October 8, 2025
- Pharma Industry Generally Welcomes New LDP Leader Takaichi
October 7, 2025
- Boehringer Ingelheim Taps Marc Hasson to Lead Japan Operations
October 7, 2025
- Chugai CEO Lauds Sakaguchi’s Nobel-Winning Work
October 7, 2025
- Alfresa, Kidswell, and Others to Form JV for Biosimilar Production in Japan
October 7, 2025
- Gilead Opens Japan Facility to Support CAR-T Delivery
October 7, 2025
- Datroway Hits Key Goals in Global PIII Trial for TNBC: Daiichi Sankyo
October 7, 2025
- SymBio Kicks Off Global PIII Trial of Brincidofovir in Europe
October 7, 2025
- Keytruda Maintains No. 1 Spot for 24th Straight Month: Encise
October 7, 2025
- Takeda Pulls Plug on Cell Therapy Work after Strategy Review
October 6, 2025
- LEO Pharma Begins Promotional Activities for Spevigo in Japan
October 6, 2025
- Sanofi Files ITP Drug Rilzabrutinib in Japan
October 6, 2025
- Moderna Reaffirms Japan Commitment, Denies Downsizing Concerns
October 3, 2025
- Regeneron Bolsters Japan Oncology Team as Libtayo Gains Ground
October 3, 2025
- Argenx Puts Japan at Core of Global Innovation Strategy
October 3, 2025
- Daiichi Sankyo Opens Third Overseas Research Hub in San Diego
October 3, 2025
- Enhertu Accepted for US Review in Pre-Surgery Setting for Early Breast Cancer
October 3, 2025
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
